Genetic Testing Company | The DNA Diagnostic Experts | GeneDx

In observance of the holidays, GeneDx will be closed for business on Thursday, December 25, 2014 and on Thursday, January 1, 2015. We will be unable to receive and process specimens. FedEx and UPS will also not be in operation. Except for the aforementioned dates, GeneDx will operate on our normal schedule (Monday-Saturday), including December 24th and December 31st.  If you have any questions or inquiries, please call us at 301-519-2100 or email us at zebras@genedx.com.

PDE6B Del/Dup

FORMS AND DOCUMENTS

TEST DETAILS

Genes:
PDE6B
Clinical Utility:
  • • Confirmation of a clinical diagnosis
  • • To differentiate ARRP, adRP, and X-linked RP from other forms of retinal dystrophy and retinal degeneration
  • • Recurrence risk assessment
  • • Prenatal diagnosis
Lab Method:
Exon Array CGH

ORDERING

Test Code:
906
Turnaround Time:
3-4 weeks
Preferred Specimen:
2-5 mL Blood - Lavender Top Tube

BILLING

CPT Codes:
84311x1, 88271x10, 88291x1
New York Approved:
Yes
ABN Required:
Yes
Billing Information:
View Billing Policy
ICD Codes:
  • 743.55: Congenital macular changes
  • 743.56: Other retinal changes, congenital
  • 743.53: Chorioretinal degeneration, congenital
  • 362.76: Dystrophies primarily involving the retinal pigment epithelium, Fundus flavimaculatus, Vitelliform dystrophy
  • 362.75: Other dystrophies
  • 743.54: Congenital folds and cysts of posterior segment
  • 362.74: Pigmentary retinal dystrophy, Retinal dystrophy, albipunctate, Retinitis pigmentosa
* For price inquiries please email zebras@genedx.com

REFERENCES

  1. Abd El-Aziz MM et al., (2007) Ann Hum Genet 71:281-94
  2. Abd El-Aziz MM et al., (2008) Nat Genet 40:1285-7
  3. Allikmets et al., (1998) Gene 215: 111- 122
  4. Bennett S et al., (2004) Pharmacogenomics 5:433-8
  5. Lotery et al., (2001) Ophthalmic Genet 22:163-9
  6. Paloma et al., (2002) J Med Genet 39:1-4
  7. Zhang et al., (2004) Mol Vis 10:884-889
  8. Dryja et al., (1995) Proc. Natl Acad Sci 92:10177-10181
  9. Weston et al., 2000 Am J Hum Genet 66:1199-210
  10. Wiszniewski W et al., (2005) Hum Mol Genet 1;14:2769-78
  11. Valverde D et al., (1996) Hum Mutat 8(4):393-4
  12. Stone E (2007) Am J Ophthalmol 144:791-811
  13. Seyedahmadi et al, (2004) Exp Eye Res 79:167-73
  14. Sandberg MA et al., (2008) Invest Ophthalmol Vis Sci 49:5532-9
  15. Rivolta C et al., (2000) Am J Hum Genet 66:1975–78
  16. Pieke Dahl S et al., (1996 ) J Med Genet 33:753-7
  17. Morimura H et al., (1998) Proc Natl Acad Sci 95:3088–3093
  18. McLaughlin ME et al., (1995) Proc Natl Acad Sci 11;92:3249-53
  19. McLaughlin ME et al., (1993) Nat Genet 4:130-4
  20. Huang SH et al., (1995) Nat Genet 11:468-71
  21. Hanein S et al., (2004) Hum Mutat 23:306-17
  22. Dryja TP et al., (1999) Invest Ophthalmol Vis Sci 40:1859-1865
  23. Dreyer B et al., (2008) Hum Mutat 29:451
  24. Dreyer B et al., (2001) Am J Hum Genet 69:228-34
  25. den Hollander et al., (2004) Hum Mutat 24:355-69
  26. den Hollander et al., (2001) Am J Hum Genet 69:198–203
  27. den Hollander et al., (1999) Nat Genet 23:217–221
  28. Danciger M et al., (1996) Mol Vis 2:10
  29. Danciger M et al., (1995) Genomics 1;30(1):1-7
  30. Collin RWJ (2009) ARVO meeting, May3-7, Fort Lauderdale, FL
  31. Collin RWJ et al., (2008) Am J Hum Genet 83:594-603
  32. Cremers FPM et al., (1998) Hum Molec Genet 7:355-362
  33. Booij JC (2005) J Med Genet 42:e67
  34. Bo Dreyer (2008) Hum Mutat 29:451
  35. Bernal S et al., (2003) J Med Genet 40:e89

Back To Top